These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8004962)

  • 21. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
    Rost S; Daniel C; Schulze-Lohoff E; Bäumert HG; Lambrecht G; Hugo C
    Kidney Int; 2002 Nov; 62(5):1659-71. PubMed ID: 12371966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydrogen peroxide-inducible clone-5 regulates mesangial cell proliferation in proliferative glomerulonephritis in mice.
    Jamba A; Kondo S; Urushihara M; Nagai T; Kim-Kaneyama JR; Miyazaki A; Kagami S
    PLoS One; 2015; 10(4):e0122773. PubMed ID: 25835392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesangial cells from transgenic mice with progressive glomerulosclerosis exhibit stable, phenotypic changes including undetectable MMP-9 and increased type IV collagen.
    Jacot TA; Striker GE; Stetler-Stevenson M; Striker LJ
    Lab Invest; 1996 Dec; 75(6):791-9. PubMed ID: 8973474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The regulation of the extracellular matrix turnover in the experimental glomerulopathies.
    Pal'tsev MA; Ivanov AA
    Ross Fiziol Zh Im I M Sechenova; 1997; 83(5-6):148-64. PubMed ID: 13677671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of TGF-beta in glomerular diseases].
    Okuda S
    Nihon Rinsho; 1992 Dec; 50(12):3032-7. PubMed ID: 1491456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Counteractive effects of HGF on PDGF-induced mesangial cell proliferation in a rat model of glomerulonephritis.
    Bessho K; Mizuno S; Matsumoto K; Nakamura T
    Am J Physiol Renal Physiol; 2003 Jun; 284(6):F1171-80. PubMed ID: 12595276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Glomerulonephritis and cell growth factors].
    Okuda S
    Fukuoka Igaku Zasshi; 1995 Mar; 86(3):75-8. PubMed ID: 7750892
    [No Abstract]   [Full Text] [Related]  

  • 28. Pathology of the human mesangium in situ.
    Waldherr R; Cuzic S; Noronha IL
    Clin Investig; 1992 Sep; 70(9):865-74. PubMed ID: 1450641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat.
    Iida H; Seifert R; Alpers CE; Gronwald RG; Phillips PE; Pritzl P; Gordon K; Gown AM; Ross R; Bowen-Pope DF
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6560-4. PubMed ID: 1713682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix.
    Okuda S; Languino LR; Ruoslahti E; Border WA
    J Clin Invest; 1990 Aug; 86(2):453-62. PubMed ID: 2200803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic expression patterns of transforming growth factor-beta(2) and transforming growth factor-beta receptors in experimental glomerulonephritis.
    Hartner A; Hilgers KF; Bitzer M; Veelken R; Schöcklmann HO
    J Mol Med (Berl); 2003 Jan; 81(1):32-42. PubMed ID: 12545247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis.
    Shankland SJ; Hugo C; Coats SR; Nangaku M; Pichler RH; Gordon KL; Pippin J; Roberts JM; Couser WG; Johnson RJ
    Kidney Int; 1996 Oct; 50(4):1230-9. PubMed ID: 8887282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apoptosis in progressive crescentic glomerulonephritis.
    Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N
    Lab Invest; 1996 May; 74(5):941-51. PubMed ID: 8642789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Administration of IgG Fc fragments prevents glomerular injury in experimental immune complex nephritis.
    Gómez-Guerrero C; Duque N; Casado MT; Pastor C; Blanco J; Mampaso F; Vivanco F; Egido J
    J Immunol; 2000 Feb; 164(4):2092-101. PubMed ID: 10657663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple roles for platelet-derived growth factor in renal disease.
    Floege J; Johnson RJ
    Miner Electrolyte Metab; 1995; 21(4-5):271-82. PubMed ID: 7565476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An overview of mesangial cell biology.
    Veis JH
    Contrib Nephrol; 1993; 104():115-26. PubMed ID: 8325023
    [No Abstract]   [Full Text] [Related]  

  • 37. Heparin-binding EGF-like growth factor is expressed by mesangial cells and is involved in mesangial proliferation in glomerulonephritis.
    Takemura T; Murata Y; Hino S; Okada M; Yanagida H; Ikeda M; Yoshioka K
    J Pathol; 1999 Nov; 189(3):431-8. PubMed ID: 10547607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone-marrow-derived cells contribute to glomerular endothelial repair in experimental glomerulonephritis.
    Rookmaaker MB; Smits AM; Tolboom H; Van 't Wout K; Martens AC; Goldschmeding R; Joles JA; Van Zonneveld AJ; Gröne HJ; Rabelink TJ; Verhaar MC
    Am J Pathol; 2003 Aug; 163(2):553-62. PubMed ID: 12875975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesangial cell turnover: effect of heparin and peptide growth factors.
    Striker LJ; Peten EP; Elliot SJ; Doi T; Striker GE
    Lab Invest; 1991 Apr; 64(4):446-56. PubMed ID: 2016850
    [No Abstract]   [Full Text] [Related]  

  • 40. Coexpression of a novel glomerular basement membrane matrix material in mesangial cell culture and glomerulosclerosis.
    Yang AH; Wang JS
    Exp Mol Pathol; 1995 Apr; 62(2):83-98. PubMed ID: 8549699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.